secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rafael Holdings, Inc. (RFL)
CIK:        0001713863
Form:       8-K
Filed at:   2024-12-23T23:59:59+00:00
Accession:  0001213900-24-111976
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Rafael Holdings converts $2.5M note into 39.5% stake in Cyclo Therapeutics
--------------------------------------------------------------------------

- Converted $2,500,000 of outstanding convertible note principal into 3,968,254 shares of Cyclo common stock.
- Conversion price set at $0.63, the December 20, 2024 closing price of Cyclo's stock on Nasdaq.
- Rafael now beneficially owns 39.5% of Cyclo Therapeutics' issued and outstanding common shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1713863/000121390024111976/0001213900-24-111976-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1713863/000121390024111976/ea0225818-8k_rafael.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-111976

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer